Search
for
Sort by
Research 721–750 of 1000+
- A Pilot Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Tofacitinib Versus Methotrexate In Moderate-to-Severe Alopecia Areata
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Ivarmacitinib stimulates hair regrowth in severe alopecia areata
- The Roles of Exosomes in Regulating Hair Follicle Growth
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
- Retrospective Study about the Effectiveness of Korean Medical Treatment on 222 Patients with Alopecia Areata
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients.
- Natural Compounds Targeting MAPK, PI3K/Akt, and JAK/STAT Signaling in Papillary Thyroid Cancer
- Microarray Gene Expression Analysis of Lesional Skin in Canine Pemphigus Foliaceus
- JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Analysis of histology and long noncoding RNAs involved in the rabbit hair follicle density using RNA sequencing
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Efficacy and safety of baricitinib in patients with refractory alopecia areata
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real‐world data
- Two cases in which tofacitinib effectively treated both ulcerative colitis and alopecia areata
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- Off-Label Treatment of Alopecia Areata—Retrospective Study
- Remission of Alopecia Areata Post-colectomy in a Patient with Crohn's Disease.
- A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata.
- The Role of Minoxidil in Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year